Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2015 (2015), Article ID 957490, 4 pages
http://dx.doi.org/10.1155/2015/957490
Case Report

Primary Vaginal Myeloid Sarcoma: A Rare Case Report and Review of the Literature

1Department of Medical and Paediatric Oncology, GCRI, Ahmedabad, Gujarat, India
2Department of Radiotherapy, Government Medical College, Haldwani, India
3Department of Pulmonary Medicine, IGMC, Shimla, Himachal Pradesh, India

Received 4 November 2014; Revised 18 December 2014; Accepted 27 December 2014

Academic Editor: Anna Fagotti

Copyright © 2015 Gaurang Modi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. W. Lee, Y. T. Kim, Y. H. Min et al., “Granulocytic sarcoma of the uterine cervix,” International Journal of Gynecological Cancer, vol. 14, no. 3, pp. 553–557, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. G. Reardon and W. C. Moloney, “Chloroma and related myeloblastic neoplasms,” Archives of Internal Medicine, vol. 108, pp. 864–871, 1961. View at Publisher · View at Google Scholar · View at Scopus
  3. J. C. Byrd, W. J. Edenfield, D. J. Shields, and N. A. Dawson, “Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review,” Journal of Clinical Oncology, vol. 13, no. 7, pp. 1800–1816, 1995. View at Google Scholar · View at Scopus
  4. R. S. Neiman, M. Barcos, C. Berard et al., “Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases,” Cancer, vol. 48, no. 6, pp. 1426–1437, 1981. View at Publisher · View at Google Scholar
  5. E. Oliva, J. A. Ferry, R. H. Young, J. Prat, J. R. Srigley, and R. E. Scully, “Granulocytic sarcoma of the female genital tract: a clinicopathologic study of 11 cases,” The American Journal of Surgical Pathology, vol. 21, no. 10, pp. 1156–1165, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Pathak, I. Bruchim, M.-L. Brisson, W. Hammouda, C. Bloom, and W. H. Gotlieb, “Granulocytic sarcoma presenting as tumors of the cervix,” Gynecologic Oncology, vol. 98, no. 3, pp. 493–497, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. P. Vachhani and P. Bose, “Isolated gastric myeloid sarcoma: a case report and review of the literature,” Case Reports in Hematology, vol. 2014, Article ID 541807, 4 pages, 2014. View at Publisher · View at Google Scholar · View at PubMed
  8. T. Y. Lan, D. T. Lin, H. F. Tien, R. S. Yang, C. Y. Chen, and K. Wu, “Prognostic factors of treatment outcomes in patients with granulocytic sarcoma,” Acta Haematologica, vol. 122, no. 4, pp. 238–246, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. A. K. Burnett, D. Milligan, A. G. Prentice et al., “A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment,” Cancer, vol. 109, no. 6, pp. 1114–1124, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. H. Tilly, S. Castaigne, D. Bordessoule et al., “Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly,” Journal of Clinical Oncology, vol. 8, no. 2, pp. 272–279, 1990. View at Google Scholar · View at Scopus
  11. M. P. Curran, “Decitabine: a review of its use in older patients with acute myeloid leukaemia,” Drugs & Aging, vol. 30, no. 6, pp. 447–458, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. Lübbert, B. H. Rüter, R. Claus et al., “A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy,” Haematologica, vol. 97, no. 3, pp. 393–401, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. A. F. Cashen, G. J. Schiller, M. R. O'Donnell, and J. F. DiPersio, “Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia,” Journal of Clinical Oncology, vol. 28, no. 4, pp. 556–561, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. H. M. Kantarjian, X. G. Thomas, A. Dmoszynska et al., “Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia,” Journal of Clinical Oncology, vol. 30, no. 21, pp. 2670–2677, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. B. Tawfik, S. Sliesoraitis, S. Lyerly et al., “Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML),” Annals of Hematology, vol. 93, no. 1, pp. 47–55, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. S. N. Singh, Q. Cao, I. Gojo, A. P. Rapoport, and G. Akpek, “Durable complete remission after single agent decitabine in AML relapsing in extramedullary sites after allo-SCT,” Bone Marrow Transplantation, vol. 47, no. 7, pp. 1008–1009, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. C. Shah, S. Gopaluni, J. Husain, A. Rajan, and H. Shah, “Granulocytic sarcoma in a patient with myelodysplastic syndrome,” Oncology, vol. 22, no. 8, pp. 950–952, 2008. View at Google Scholar · View at Scopus
  18. Y. Lou, W. Qian, H. Meng, Y. Tong, and J. Jin, “Frequent extramedullary recurrence of isolated myeloid sarcoma in the long-term follow-up,” Annals of Hematology, vol. 91, no. 8, pp. 1317–1319, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus